Rodino-Klapac Louise — SEC insider filings
SEC reporting owner CIK 1836218. 30 insider filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2020-12-14 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 3,780 shares, $299,867 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 55.
- Largest priced transaction: purchase of 3,780 shares @ $79.33 ($299,867) in Sarepta Therapeutics, Inc., filed 2021-11-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | 30 | 1 leg · 3,780 sh · $299,867 | — | 55 |
Insider filings — Rodino-Klapac Louise
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 21,423 @ $22.22 | EDGAR |
| 2026-03-13 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 948 @ $17.03 | EDGAR |
| 2026-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 504 @ $16.95 · Tax withholding (F): 895 @ $16.95 | EDGAR |
| 2026-03-03 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 8,125 · Tax withholding (F): 3,718 @ $16.20 · Tax withholding (F): 767 @ $16.20 · Option exercise (M): 8,125 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 1,875 (derivative) | EDGAR |
| 2025-11-19 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 4,582 @ $18.42 | EDGAR |
| 2025-09-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 93,875 @ $0 · Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-08-06 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 6,250 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 5,500 · Tax withholding (F): 924 @ $100.13 · Tax withholding (F): 2,539 @ $100.13 · Grant/award (A): 8,276 · Option exercise (M): 5,500 (derivative) @ $0 · Grant/award (A): 16,644 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 17,500 · Tax withholding (F): 514 @ $103.70 · Tax withholding (F): 7,990 @ $103.70 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 1,704 @ $101.34 | EDGAR |
| 2025-03-04 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 715 @ $103.77 | EDGAR |
| 2025-02-13 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 3,500 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 4,558 @ $102.89 | EDGAR |
| 2024-06-25 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 6,250 · Tax withholding (F): 2,182 @ $164.64 · Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 512 @ $120.49 · Tax withholding (F): 909 @ $123.14 | EDGAR |
| 2024-03-06 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 1,728 @ $125.32 | EDGAR |
| 2024-03-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 778 @ $126.19 · Grant/award (A): 6,000 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2023-11-20 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 4,508 @ $82.98 | EDGAR |
| 2023-03-10 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 912 @ $153.19 | EDGAR |
| 2023-03-08 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 1,134 @ $157.21 · Grant/award (A): 4,500 @ $0 · Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 522 @ $147.57 | EDGAR |
| 2022-11-21 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 4,211 @ $108.52 | EDGAR |
| 2022-03-08 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 1,216 @ $79.20 · Grant/award (A): 8,000 @ $0 · Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2022-03-01 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 572 @ $75.05 | EDGAR |
| 2021-11-29 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Purchase (P): 3,780 @ $79.33 | EDGAR |
| 2021-11-17 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2021-03-10 | 4/A | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 565 @ $86.97 · Grant/award (A): 15,000 @ $0 | EDGAR |
| 2021-03-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2020-12-14 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1836218 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs